Facilitated By

San Antonio Medical Foundation

Development of a Multivalent Biodefense Vaccine

The University of Texas at San Antonio

The University of Texas at San Antonio is an emerging Tier One research institution with nearly 29,000 students.

Principal Investigator(s)
Klose, Karl
Funded by
NIH Natl Inst of Allergy/Infectious Dise
Research Start Date
Status
Active

Basic Research

Collaborative Project
Basic Research
Aging